Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 16.82 % in the past year, substantial increase in net sales/revenue by 20.81 %.
- Income over the Year and quarter: Marginal decrease of % in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Hindustan Bio Sciences Ltd.. Notable increase of 233.33 % in net profit Year to Year, Hindustan Bio Sciences Ltd.’s profitability dropped by -42.03 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 300.00 % Year to Year. EPS decreased by -42.86 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.333 Cr | Rs. 0.322 Cr | Rs. 0.389 Cr | + 20.81 % | + 16.82 % |
| Expenses | Rs. 0.32 Cr | Rs. 0.27 Cr | Rs. 0.35 Cr | + 29.63 % | + 9.37 % |
| Operating Profit | Rs. 0.01 Cr | Rs. 0.05 Cr | Rs. 0.04 Cr | -20 % | + 300 % |
| OPM % | 3 % | 15.53 % | 10.28 % | -5.25 % | + 7.28 % |
| Other Income | Rs. -0 Cr | Rs. 0.02 Cr | Rs. -0 Cr | 0 % | 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. 0.01 Cr | Rs. 0.07 Cr | Rs. 0.04 Cr | -42.86 % | + 300 % |
| Tax % | 21.43 % | 0 % | 0 % | 0 % | -21.43 % |
| Net Profit | Rs. 0.01 Cr | Rs. 0.07 Cr | Rs. 0.04 Cr | -42.86 % | + 300 % |
| EPS in Rs | Rs. 0.01 | Rs. 0.07 | Rs. 0.04 | -42.86 % | + 300 % |
Today, we’re looking at Hindustan Bio Sciences Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 16.82 %. However, it did see a marginal increase of 20.81 % from the previous quarter. Expenses ticked up slightly by 29.63 % quarter-on-quarter, aligning with the annual rise of 9.37 %. Operating profit, while up 300 % compared to last year, faced a quarter-on-quarter dip of -20 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 7.28 %, but a shrinkage of -5.25 % sequentially. Profit before tax grew annually by 300 % but saw a reduction from the preceding quarter by -42.86 %.
Tax expenses as a percentage of profits decreased slightly by -21.43 % compared to last year, Net profit rose by 300 % year-on-year but witnessed a -42.86 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 300 % but a quarterly fall of -42.86 %. In summary, Hindustan Bio Sciences Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.333 Cr | Rs. 0.322 Cr | Rs. 0.389 Cr | + 20.81 % | + 16.82 % |
| Expenses | Rs. 0.32 Cr | Rs. 0.27 Cr | Rs. 0.35 Cr | + 29.63 % | + 9.37 % |
| Operating Profit | Rs. 0.01 Cr | Rs. 0.05 Cr | Rs. 0.04 Cr | -20 % | + 300 % |
| Net Profit | Rs. 0.01 Cr | Rs. 0.07 Cr | Rs. 0.04 Cr | -42.86 % | + 300 % |
| EPS in Rs | Rs. 0.01 | Rs. 0.07 | Rs. 0.04 | -42.86 % | + 300 % |
In reviewing Hindustan Bio Sciences Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 16.82 % year-on-year growth, however, there was a minor increase of 20.81 % from the previous quarter. Expenses rose by 9.37 % compared to the previous year, with a 29.63 % increase quarter-on-quarter. Operating Profit surged by 300 % annually, and saw a -20 % decrease from the last quarter.
Net Profit showed yearly increase of 300 %, and experienced a -42.86 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 300 % annually, however dipped by -42.86 % compared to the last quarter. In essence, while Hindustan Bio Sciences Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
